Trial
NCT02567149
Intralesional Cidofovir for the Treatment of Recalcitrant Warts in the Pediatric Immune-suppressed Population.
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Minnesota
Collaborators
—
Condition
Warts
Intervention
Cidofovir
Why stopped
No funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-07-02